Alliance Pharma plc (AIM:APH)
London · Delayed Price · Currency is GBP · Price in GBX 64.70
0.00 (0.00%)
Inactive · Last trade price on May 13, 2025
Alliance Pharma Company Description
Alliance Pharma plc, a holding company, acquires, markets, and distributes consumer healthcare products and prescription medicines in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas.
It provides its products under the Aloclair, Anbesol, Asthon & Parsons, Forceval, Hydromol, Kelo-Cote, MacuShield, Vamousse, Nizoral, and Amberen brand names.
The company was incorporated in 1996 and is headquartered in Chippenham, the United Kingdom. As of May 14, 2025, Alliance Pharma plc was taken private.
Alliance Pharma plc
| Country | United Kingdom |
| Founded | 1996 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 290 |
| CEO | Nicholas Sedgwick |
Contact Details
Address: Avonbridge House Chippenham, SN15 2BB United Kingdom | |
| Phone | 44 12 4946 6966 |
| Website | alliancepharmaceuticals.com |
Stock Details
| Ticker Symbol | APH |
| Exchange | London Stock Exchange AIM |
| Fiscal Year | January - December |
| Reporting Currency | GBP |
| ISIN Number | GB0031030819 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Nicholas Sedgwick | Chief Executive Officer |
| Andrew Franklin | Chief Financial Officer |
| Cora McCallum | Head of Investor Relations |